The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
30
No.
21
May 21, 2004
- NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.
- In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.
- HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize.
- Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.
- In Brief: ASCO awards career development grants.
- Funding Opportunities listed.
TCL
Vol.
30
No.
22
May 28, 2004
- FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.
- Also in this 8-page issue: Cooperative groups tell Congress that NCI’s $115 million in support for adult cancer clinical trials is “chump change.” Trials would close faster, report results sooner, if funding were increased, regulatory issues streamlined.
- Larry Norton wins ASCO’s Karnofsky award.
- Funding opportunities listed.
- May issue of Business & Regulatory Report, 8 additional pages, included.
CCL
Vol.
27
No.
5
May 28, 2004
- Radiation Therapy Combination Better For Treating Cancer Spread To Brain
- Biopsy System Effective In Removing Benign Breast Masses, Study Finds
- New Drug for Lymphoma Enters Phase II Trial
- Wilex, Fox Chase, Begin Trial Of WX-UK1 Targeting Invasion
- Study Begins On Link Between Down Syndrome, Leukemia
- Trial Begins To Test Method To Test For Colorectal Cancer
- Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar
- Chemo, Radiation Improves DFS In Head & Neck Cancer
- Medline Plus Provides Info To Patients About Prescriptions
- NCI-Approved Clinical Trials
TCL
Vol.
30
No.
23
June 04, 2004
- A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.
- Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists.
- Age-adjusted cancer incidence and mortality down slightly, annual report finds.
- Bills in House, Senate, would give FDA authority over tobacco products.
- Surgeon General’s report adds to list of smoking-related cancers, other diseases.
- ASCO honors physicians for clinical trials participation.
- President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.
- Funding opportunities listed.
TCL
Vol.
30
No.
24
June 11, 2004
- The Centers for Medicare and Medicaid Services and NCI said they are developing a Memorandum of Understanding to address how the agencies can work together to improve the process for making coverage decisions for cancer therapy and diagnosis.
- Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.
- Access to mammography needs improvement, IOM National Cancer Policy Board report finds.
- NCAB, President’s Cancer Panel honor the late Paul Calabresi.
- Funding opportunities listed.
TCL
Vol.
30
No.
25
June 18, 2004
- NCI is developing review criteria for a Cancer Center Loan Program that would provide $200 million in loans for capital improvements to qualified centers. NCAB member Eric Lander criticizes limited discussion, “lack of vision” for the loan program.
- NCI Director asks NCAB to pray for him.
- NCI prepares for third hearing on conflicts of interest.
- Waxman urges drug companies to list clinical trials on NIH Web site.
- NIH Chemical Genomics Center to screen small molecules.
- Knudson wins Kyoto prize; King wins genetics prize.
- Funding opportunities listed.
TCL
Vol.
30
No.
26
June 25, 2004
- NIH to ban consulting by top officials, limit outside work by other employees.
- Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.
- White House names five to NCAB, reappoints Niederhuber as chairman.
- Cancer survivors number 9.8 million in U.S., CDC says.
- Cigarette use declining among high school students, report finds.
- University of Wisconsin wins $7 million NIH construction grant for cancer center.
- Vanderbilt physician-scientist Philip Browning, 51, dead of colon cancer.
- Funding opportunities listed.
CCL
Vol.
27
No.
6
June 25, 2004
- ASCO Annual Meeting: New Therapeutic Approaches To Breast Cancer Highlighted
- Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment
- Weekly Paclitaxel Better Than Every Three Weeks
- Pharmacogenomics May Lead To Individualized Treatment
- ASCO Recommends Against Chemo In Stage II Colon Cancer
- NCI-Approved Clinical Trials